Perimeter Medical Imaging Inc Appoints Charles S.

Carignan, MD as New CEO

Toronto, Canada, June 26, 2018 --(PR.com)-- Perimeter Medical Imaging Inc., a developer of real time
imaging systems for in-surgery tissue assessment, is pleased to announce the appointment of Charles S.
Carignan, MD as CEO.

Dr. Carignan has more than 20 years of experience in key leadership positions spanning the medical
imaging, women's health, surgery and rehabilitation sectors. He brings a proven track record of
successfully commercializing a number of breakthrough technologies that dramatically improved
healthcare for patients. Most recently he has served as CEO of REX Bionics, a developer of robotic
rehabilitation systems designed for people with mobility impairments.

As CEO of BionX Medical Technologies he led the commercialization and redesign of the world's only
active prosthetic foot and ankle solution available in the market - the Empower Ankle. BionX was
acquired by Ottobock in 2017. Prior to this he built the team that developed the NvisionVLE™ Imaging
System, an Optical Coherence Tomography (OCT) imaging system for gastrointestinal applications
developed by NinePoint Medical, where he was founder and CEO. Other notable positions include
Executive Vice President and Chief Medical Officer of Novasys Medical, Inc., Chief Medical Officer at
Boston Scientific, and Vice President of Clinical Research and Medical Affairs at Conceptus. He is also a
Director of Aegea Medical, the developer of the Aegea Vapor System for endometrial ablation.

Dr. Carignan earned his undergraduate degree from Yale University, received his M.D. degree from the
College of Physicians and Surgeons of Columbia University and trained in general surgery at
Columbia-Presbyterian Medical Center.

“Perimeter's success to date has been driven by an incredibly strong team. As we prepare for the next
phase of growth, we are happy to be adding world class senior talent who will lay a foundation for our
future success. Chuck's experience developing and commercializing innovative OCT based tissue
imaging solutions is an incredible fit for Perimeter” Paul Weber, Perimeter's founder and Chief Business
Officer notes. “His proven ability to navigate regulatory, reimbursement and early market
commercialization environment will be an invaluable asset.”

“Perimeter's OTIS™ Optical Tissue Imaging System is poised to make a major impact on the tissue
specimen imaging market,” said Dr. Carignan. “The team has done an incredible job developing OTIS™
and establishing strong clinical and strategic relationships that will be the basis for widespread adoption.
It is exciting to join such a dynamic team.”

About Perimeter Medical Imaging Inc.

Perimeter Medical Imaging develops, patents and commercializes advanced surgical imaging tools that
allow surgeons, radiologists and pathologists to better assess microscopic tissue structures during the
surgical procedure. Perimeter's OTIS™ is the only solution that provides clinicians with a high resolution
sub-surface image of the entire surface of the removed tissue specimen, providing accurate information in

Page 1/3
PR.com Press Release Distribution Terms of Use
real time and enabling more informed surgical decisions. Perimeter is a privately owned Canadian
company. For more information, visit www.perimetermed.com.

For more information visit us on the web at www.perimetermed.com or email us at

pweber@perimetermed.com

Page 2/3
PR.com Press Release Distribution Terms of Use
Contact Information:
Perimeter Medical Imaging Inc
Dawna Panas
647-360-0302
Contact via Email
www.perimetermed.com
hours of operation - 8-4 Monday - Friday

Online Version of Press Release:

You can read the online version of this press release at: https://www.pr.com/press-release/757773

Page 3/3
PR.com Press Release Distribution Terms of Use